Lloyd A. Rowland

Companies

• CytomX Therapeutics, Inc.General counsel Jun 15, 2018 to now¹
• Xencor IncGeneral counsel Sep 2, 2014 to Jan 28, 2016²
• Amylin PharmaceuticalsVP, Gov/Compliance, Secretary May 2, 2007 to Aug 10, 2012³
• Amylin PharmaceuticalsGeneral counsel Jan 4, 2006 to Apr 3, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCytomX Therapeutics, Inc. CTMX120,594 shares⁵$275.0K at $2.28Mar 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 18, 2025Sold 10,203 shares at $0.60 of CytomX Therapeutics, Inc.⁵
• Aug 20, 2024Sold 4,181 shares at $1.23 of CytomX Therapeutics, Inc.⁶
• Aug 20, 2024Exercised options 11,250 shares of CytomX Therapeutics, Inc.⁶
• Mar 19, 2024Sold 5,268 shares at $2.09 of CytomX Therapeutics, Inc.⁷
• Jan 18, 2024Granted 25,000 shares of CytomX Therapeutics, Inc.⁸
• Dec 20, 2023Sold 4,077 shares at $1.38 of CytomX Therapeutics, Inc.⁹
• Dec 17, 2023Exercised options 11,250 shares of CytomX Therapeutics, Inc.¹⁰
• Sep 22, 2023Sold 5,486 shares at $1.30 of CytomX Therapeutics, Inc.¹¹
• Sep 20, 2023Granted 15,000 shares of CytomX Therapeutics, Inc.¹¹
• Mar 16, 2023Sold 2,037 shares at $1.98 of CytomX Therapeutics, Inc.¹²
• Feb 2, 2023Granted 25,000 shares of CytomX Therapeutics, Inc.¹³
• Jul 20, 2022Sold 5,602 shares at $1.42 of CytomX Therapeutics, Inc.¹⁴
• Jul 19, 2022Granted 15,000 shares of CytomX Therapeutics, Inc.¹⁴
• Feb 2, 2022Granted 22,500 shares of CytomX Therapeutics, Inc.¹⁵